- Advertise
- Contact Us
- Contribute
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
- About Us
© 2021 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
Cardiovascular Disease
Physician Perspective: AHA Guidelines on Managing CVD Risk During Menopause
December 20, 2020
Dr. Gregory Weiss offers perspective on a recent guideline update from the American Heart Association outlining strategies to best manage risk of cardiovascular disease in women entering menopause.
Intensive Glucose, Blood Pressure Control Reduces Risk of Cardiovascular Autonomic Neuropathy
December 17, 2020
An analysis of more than 7k patients with CAN data from the ACCORD trial suggest intensive blood pressure and blood glucose control could reduce risk of cardiovascular autonomic neuropathy.
Study Examines How Age at Diabetes Diagnosis Predicts Risk of Complications Later in Life
December 15, 2020
An analysis of more than 25 studies with more than 1 million patients is giving an overview of how the timing of a diabetes diagnosis can impact risk of complications later in life.
Weight Loss Surgery Bests Medical Therapy for Reducing CVD in Obese Teens
December 13, 2020
An analysis of 2 major studies is comparing the effects of bariatric surgery vs standard medical therapy on risk of cardiovascular disease events in obese teens with type 2 diabetes.
SGLT2 Inhibitors for Primary Prevention: The Future of Care?
December 11, 2020
A resident from Penn State Hershey Medical Center offers perspective on the idea of using SGLT2 inhibitors for primary prevention in patients with type 2 diabetes.
Gender Gaps in Care Following Heart Attack Still Persist
December 04, 2020
An analysis of data over a 12-year period details the disparities in outcomes following first heart attack among female versus male patients.
Greater Long-Term HbA1c Variability Increases Risk of All-Cause, Cardiovascular Death
December 02, 2020
An analysis of the Look AHEAD study by investigators at Johns Hopkins details associations between long-term variability of glycemic markers and increased risk of all-cause and cardiovascular mortality.
Increased Sedentary Behavior Raises Heart Failure Risk in Women
November 29, 2020
An analysis of data from the Women's Health Initiative suggests spending more than 6.5 hours engaged in sedentary behaviors each day was linked to a 42% increase in risk of heart failure in older women.
FIDELIO-DKD Analysis Suggests Finerenone Use Could Reduce Cardiovascular Events
November 23, 2020
An analysis of cardiovascular outcomes from FIDELIO-DKD suggest finerenone use was associated with a 14% reduction in negative cardiovascular outcomes.
Comparing Cost-Effectiveness of Antihyperglycemic Agents with Cardiovascular Benefit
November 21, 2020
In a recent column Gregory Weiss, MD, uses studies from AHA Scientific Sessions 2020 to compare the cost-effectiveness of antihyperglycemic agents for reducing cardiovascular events.